全文获取类型
收费全文 | 136707篇 |
免费 | 9529篇 |
国内免费 | 630篇 |
专业分类
耳鼻咽喉 | 1653篇 |
儿科学 | 3429篇 |
妇产科学 | 2462篇 |
基础医学 | 17507篇 |
口腔科学 | 2899篇 |
临床医学 | 13413篇 |
内科学 | 28101篇 |
皮肤病学 | 1760篇 |
神经病学 | 12057篇 |
特种医学 | 5418篇 |
外科学 | 21886篇 |
综合类 | 1949篇 |
现状与发展 | 1篇 |
一般理论 | 174篇 |
预防医学 | 12528篇 |
眼科学 | 2946篇 |
药学 | 9638篇 |
2篇 | |
中国医学 | 181篇 |
肿瘤学 | 8862篇 |
出版年
2023年 | 673篇 |
2022年 | 1059篇 |
2021年 | 2585篇 |
2020年 | 1472篇 |
2019年 | 2407篇 |
2018年 | 2932篇 |
2017年 | 2118篇 |
2016年 | 2246篇 |
2015年 | 2728篇 |
2014年 | 4031篇 |
2013年 | 6085篇 |
2012年 | 8899篇 |
2011年 | 9458篇 |
2010年 | 5262篇 |
2009年 | 4821篇 |
2008年 | 8399篇 |
2007年 | 9006篇 |
2006年 | 8590篇 |
2005年 | 8742篇 |
2004年 | 8399篇 |
2003年 | 7898篇 |
2002年 | 7697篇 |
2001年 | 1306篇 |
2000年 | 1099篇 |
1999年 | 1428篇 |
1998年 | 1638篇 |
1997年 | 1313篇 |
1996年 | 1258篇 |
1995年 | 1223篇 |
1994年 | 1037篇 |
1993年 | 1011篇 |
1992年 | 864篇 |
1991年 | 888篇 |
1990年 | 782篇 |
1989年 | 755篇 |
1988年 | 767篇 |
1987年 | 755篇 |
1986年 | 768篇 |
1985年 | 852篇 |
1984年 | 917篇 |
1983年 | 872篇 |
1982年 | 1142篇 |
1981年 | 1164篇 |
1980年 | 969篇 |
1979年 | 640篇 |
1978年 | 677篇 |
1977年 | 602篇 |
1976年 | 521篇 |
1975年 | 475篇 |
1974年 | 483篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
71.
72.
Christabel E. Fowler Elia Beniash Yasuo Yamakoshi James P. Simmer Henry C. Margolis 《European journal of oral sciences》2006,114(S1):297-303
An amorphous silica mineralization technique was used to produce inorganic/protein composites to elucidate the structure and mechanism of formation of amelogenin assemblies, which may play an important role in regulating enamel structure during the initial stages of amelogenesis. Full-length recombinant amelogenins from mouse (rM179) and pig (rP172) were investigated along with key degradation products (rM166 and native P148) lacking the hydrophilic C terminus found in parent molecules. The resulting products were examined using transmission electron microscopy and/or small-angle X-ray scattering. Using protein concentrations of 0.1–3 mg ml−1 , large monodisperse spheres of remarkably similar mean diameters were observed using rM179 (124 ± 4 nm) and rP172 (126 ± 7 nm). These spheres also exhibited 'internal structure', comprising nearly spherical monodisperse particles of ≈ 20 nm in diameter. In the presence of rM166, P148, and bovine serum albumin (control), large unstructured and randomly shaped particles (250–1000 nm) were observed. Without added protein, large dense spherical particles of silica (mean ≈ 500 nm) lacking internal structure were produced. These findings demonstrate that full-length amelogenins have the ability to form higher-order structures, whereas amelogenins that lack the hydrophilic C terminus do not. The results also suggest that full-length amelogenin can guide the formation of organized mineralized structures through co-operative interactions between assembling protein and forming mineral. 相似文献
73.
74.
75.
Najat C Daw Wayne L Furman Clinton F Stewart Lisa C Iacono Mark Krailo Mark L Bernstein Janet E Dancey Rose Anne Speights Susan M Blaney James M Croop Gregory H Reaman Peter C Adamson 《Journal of clinical oncology》2005,23(25):6172-6180
PURPOSE: Epidermal growth factor receptor is expressed in pediatric malignant solid tumors. We conducted a phase I trial of gefitinib, an epidermal growth factor receptor tyrosine kinase inhibitor, in children with refractory solid tumors. PATIENTS AND METHODS: Gefitinib (150, 300, 400, or 500 mg/m2) was administered orally to cohorts of three to six patients once daily continuously until disease progression or significant toxicity. Pharmacokinetic studies were performed during course one (day 1 through 28). RESULTS: Of the 25 enrolled patients, 19 (median age, 15 years) were fully evaluable for toxicity and received 54 courses. Dose-limiting toxicity was rash in two patients treated with 500 mg/m2 and elevated ALT and AST in one patient treated with 400 mg/m2. The maximum-tolerated dose was 400 mg/m2/d. The most frequent non-dose-limiting toxicities were grade 1 or 2 dry skin, anemia, diarrhea, nausea, and vomiting. One patient with Ewing's sarcoma had a partial response. Disease stabilized for 8 to > or = 60 weeks in two patients with Wilms' tumor and two with brainstem glioma (one exophytic). At 400 mg/m2, the median peak gefitinib plasma concentration was 2.2 microg/mL (range, 1.2 to 3.6 microg/mL) and occurred at a median of 2.3 hours (range, 2.0 to 8.3 hours) after drug administration. The median apparent clearance and median half-life were 14.8 L/h/m2 (range, 3.8 to 24.8 L/h/m2) and 11.7 hours (range, 5.6 to 22.8 hours), respectively. Gefitinib systemic exposures were comparable with those associated with antitumor activity in adults. CONCLUSION: Oral gefitinib is well tolerated in children. Development of the drug in combination with cytotoxic chemotherapy will be pursued. 相似文献
76.
77.
78.
Lidong Zhang James E Littlejohn Yu Cui Xiaobo Cao Chander Peddaboina W Roy Smythe 《Molecular cancer》2010,9(1):110
Background
Bortezomib, a proteasome-specific inhibitor, has emerged as a promising cancer therapeutic agent. However, development of resistance to bortezomib may pose a challenge to effective anticancer therapy. Therefore, characterization of cellular mechanisms involved in bortezomib resistance and development of effective strategies to overcome this resistance represent important steps in the advancement of bortezomib-mediated cancer therapy. 相似文献79.
80.